Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company that develops innovative mobile health (mHealth) and telemedicine solutions for the community-based healthcare market, is pleased to announce that it has signed an agreement with AnglicareSA in Adelaide, Australia to provide its iUGO Care remote patient monitoring platform to their home care clients on a trial basis.
“We are very excited to be working with AnglicareSA to improve access to care for older Australians,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “AnglicareSA operates six residential care facilities and provides home care to more than 1,500 Australians. The iUGO Care platform will enable AnglicareSA to trial remote patient monitoring services for clients in their own homes, improving access to care for patients with chronic diseases. Reliq is starting to gain significant traction in Australia, where the government has made home care a priority with the Increasing Choice in Home Care measure, implemented in 2017. With over 3.5 million Australians aged 65 and over and a progressive single payer system that has committed significant funding to home care, the Australian market is a perfect fit for Reliq’s iUGO Care platform.”
“AnglicareSA respects and cares for older people in their own homes, in residential aged care facilities and in the community,” said Daniel Aitchison, of AnglicareSA. “We are committed to supporting older people to live full and rewarding lives and to respecting their choices. We look forward to trialing Reliq Health remote monitoring services as we continue to deliver high quality care and support to our clients and their families.”
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
ABOUT RELIQ HEALTH
Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.
Could be a major source of revenuenot only in Australia but
Many other countries with isolated populations eg Canada, India
Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company that develops innovative mobile health (mHealth) and telemedicine solutions for the community-based healthcare market, is pleased to announce that it has signed an agreement to conduct a three month paid pilot of its iUGO Care remote patient monitoring platform with the Royal Flying Doctor Service Central Operations (RFDS) in Australia, beginning this Fall.
“We are very excited to be working with the RFDS to improve health outcomes for individuals and their communities with this pilot in rural and remote South Australia,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Approximately half a million people (2.05 percent of the Australian population) live in remote and very remote communities in Australia. Research by the RFDS has shown that remote Australians are 1.6 times more likely to be hospitalized for coronary heart disease than people in major cities and 1.3 times more likely to die. We look forward to working with the RFDS to improve health outcomes for these patients.”
The iUGO Care platform allows a patient’s care team to remotely monitor vital signs such as blood pressure, blood glucose, heart rate, oxygen saturation and lung function, and receive automated alerts if there are any abnormalities in these readings. iUGO Care allows the entire circle of care to be connected and informed, enabling better health outcomes, lower cost of care and improved quality of life.
The RFDS (www.flyingdoctor.org.au) is one of the largest and most comprehensive aeromedical organizations in the world, providing extensive primary health care and 24-hour emergency service to people over an area of 7.69 million square kilometres. In 2017 over 336,000 patient encounters occurred through RFDS primary health clinics, aeromedical transports and telehealth consultations. The challenges of health access outside Australia’s cities make the RFDS vital to those who live, work and travel in rural and remote Australia.
Reliq Health Technologies Inc. (TSXV:RHT) (OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company that develops innovative mobile health (mHealth) and telemedicine solutions for the Community-Based Healthcare market, is pleased to announce that it has received the first shipment of backordered Remote Monitoring devices and will now be able to resume onboarding new patients.
“We are pleased to announce that we have received the first of several shipments of Remote Monitoring devices and will now be able to resume onboarding new patients,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “We would like to thank our customers for their patience over the last few months and look forward to working with them to onboard new patients to the iUGO Care remote patient monitoring platform. We remain committed to helping our clients deliver high quality virtual care to at-risk patients in underserved communities”.
Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq's powerful iUGO Care platform supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.
RHT.v -.01 to C$1.50 Bought in yesterday and today. Have been watching Reliq and noticed the huge fall in share price over the past few months. My avg is C$1.45. Guessing it was investors selling stock and holding warrants from past raises.
Listened to conference call today. CEO can talk nonstop but information seems good. Delays in onboarding probably means qtr ending 6/30 will be similar to Q3 ending 3/31. Revs will be about 1.8 million but hopefully they won't grant another $3+million in options!!!! and get closer to breakeven. Said they were keeping guidance for calendar year 12/18 so expecting new equipment coming in June AND new help in setting up new clients to accelerate new clients onboarding thru year end.
Mentioned new, bigger sales staff and new prospects in Texas as well as other jurisdictions. Says margins will remain very high near 80%.
Said no further stock issuance needed this year unless they find a compelling acquisition. Had C$13million from last raise at 3/31/18. Spent some of that on big order for equipment that they will recover as new patients are onboarded.
The Financial Post reports in its Saturday edition that small-cap stocks are more fun to analyze (who needs to read 40 analyst reports on BCE, anyways?), but they are also often more profitable for investors than large companies. Post columnist Peter Hodson writes that one of his favourites is Reliq Health Technologies which, at $1.55, has a market cap of $177-million. Reliq Health Technologies shares are up 37 per cent this year alone and more than 1,000 per cent in the past 52 weeks. Certainly, that is the type of small-cap performance to keep the punters happy. Reliq is a growing company in the health care monitoring industry. Its business allows doctors to remotely monitor and advise patients in their own homes. With new contracts, revenue is expected to go from near zero to more than $26-million in the next year. The firm has some cash but will likely need more if it continues to grow quickly. Keep in mind that small companies can be inherently riskier than large companies. They do not have the executive depth, financial resources or the cash flow large companies typically have. When buying small caps, your investment time frame should be longer, and you should go in expecting share-price volatility.
Here is excellent news!!
"Post says StoneCastle plugs into Reliq Health
2018-05-22 07:37 CT - In the News
Shares issued 101,901,914
RHT Close 2018-05-18 C$ 1.81
The Financial Post reports in its Saturday edition that technology companies have turned their attention to devices, creating sophisticated networks that make up the so-called Internet of Things (IoT). The Post's David Dias writes that portfolio managers have begun taking notice of a few Canadian small caps that could prominently figure in the machine chatter of the future. One of these is Reliq Health Technologies ($1.81). Bruce Campbell at StoneCastle Investment likes this service provider, which connects to health sensors in the home in order to track a patient's vital signs. Those data are then streamed in real time to health-care workers. Reliq monitors vital signs such as blood pressure and blood sugar levels, and can even remind patients to take their medication through a voice-enabled Alexa-style interface. The idea is to help hospitals cut down on expensive readmissions, and Reliq has already made strides selling to health authorities in the United States, recently breaking through to profitability. Canada's public health-care system will be harder to penetrate, but a pilot project serving first nations communities is in the works, and Mr. Campbell thinks Reliq could soon garner a lot of attention."
Reliq Health Technologies Inc. (TSXV:RHT) (OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company that develops innovative mobile health (mHealth) and telemedicine solutions for the Community-Based Healthcare market, is pleased to announce that it has signed a Memorandum of Understanding with ForaCare Inc. of Moorpark, CA to address hardware availability for iUGO Care customers.
“We are very pleased to have partnered with ForaCare Inc. to help our customers provide their remote and rural patients with cellular-enabled monitoring devices,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Reliq’s iUGO Care platform is hardware-agnostic, meaning that our clients can choose whichever monitoring devices they feel will work best for their patients. Many of our clients in Texas who work in underserved communities where there are no internet service providers require monitoring devices that can collect and share patient data over a cellular network. ForaCare’s D40g 2-in-1 blood glucose and blood pressure monitoring device is SIM card-enabled and ideally suited to these applications. This partnership will allow us to work closely with ForaCare on forecasts to ensure adequate device supply for our clients going forward.
“Our mission at ForaCare is to enable accurate and easy to use in-home biometric monitoring even for patients in communities without conventional internet access,” said Derek Lin, CEO, ForaCare Global. “We are excited to have achieved significant growth with our FORA D40g SIM card-enabled blood glucose and blood pressure monitoring device. We look forward to working with Reliq Health to ensure positive health outcomes for their current and future customers.”
Based in Moorpark, California, ForaCare Inc. is a technology company dedicated to the design, development, and marketing of innovative medical device products for chronic disease management. The aim of ForaCare Inc. is to complete the cycle of chronic disease management by combining innovative medical device technologies and clinical software applications.
Reliq Health Technologies Announces Expansion of Paz Home Health Contract by 5,000 New Patients, Increasing Contract Value to over $9MM USD Annually
-- Reliq Health Technologies Inc. (TSXV:RHT) (OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company that develops innovative mobile health (mHealth) and telemedicine solutions for the Community-Based Healthcare market, is pleased to announce the expansion of its contract with Paz Home Health LLC in Texas to provide its iUGO Care remote patient monitoring and telemedicine solution. The revised contract increases the number of Paz Home Health subscribers by 5,000 patients, bringing the total to over 15,000 patients total. This will generate over $9 Million USD in annual recurring revenue at full deployment, by Q4 2018.
“We are excited to announce that as a result of their implementation of the iUGO Care remote patient monitoring platform, our client Paz Home Health has been accepted as a Superior HealthPlan Approved Provider for in-home telemonitoring. Superior HealthPlan is a managed care organization that works with the State of Texas Health and Human Services Commission to deliver care through approved providers to Medicare and Medicaid patients. As a result of becoming an Approved Provider, Paz has increased their registered Medicare/Medicaid homecare clients to over 15,000 patients across Southern Texas,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Paz Home Health has successfully demonstrated the benefits of using Reliq’s iUGO Care remote patient monitoring system to improve health outcomes and reduce hospital admissions and ER visits in their patients. Reliq’s technology allows Paz Home Health’s patients to receive high quality care from the comfort of their own homes, reducing the cost of care delivery and increasing patient and family satisfaction.”
“Our mission at Paz Home Health is to provide peace of mind for patients and their loved ones,” said Dayana Bermea, CEO. “We are excited to have achieved Superior HealthPlan Approved Provider status and look forward to continuing to grow our patient base in Southern Texas and throughout the State. At Paz Home Health we are always striving to provide our clients with best in class home healthcare.”
Paz Home Health LLC is a Superior HealthPlan-approved home care provider headquartered in Pharr, Texas that provides care to patients across 16 counties in southern Texas. Paz Home Health delivers in-home care from Registered and Licensed Vocational Nurses, Physical and Occupational Therapists, Medical Social Workers and Dieticians. The company also offers telemonitoring services to connect patients with their care team from the comfort of their own homes. Paz Home Health’s caring and qualified healthcare providers are committed to supporting patients and families who are coping with chronic conditions like Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD) and Diabetes, recovering at home from surgery or injuries, and seniors who are aging in place.
Reliq Health Technologies Inc. (TSXV:RHT) (OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to provide an update on operations to current and future shareholders.
“This has been an extraordinarily busy and productive three months for Reliq Health,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies. “We’ve been very internally focused this quarter, working to evolve from a start up to a mature organization with the necessary infrastructure to support the growth we anticipate going forward. We have now successfully built a strong foundation that will allow the Company to ramp up client acquisition and patient enrollment to address the significant opportunities in our pipeline. The Company has undertaken major new initiatives including hiring an experienced Sales team, implementing new CRM and Accounting systems, moving our code in house, opening a US office and expanding our Implementation, Technical Leadership, Finance and IR teams. We’ve continued to execute on our business plan and meet our milestones as forecast, including our go-live with Sioux Lookout Meno Ya Wen Health Centre in Ontario and ongoing patient enrollment at our customer sites in Texas, despite the intense effort required by our internal corporate initiatives. I’d like to thank my entire team for all of the hard work and long hours they’ve put in over the past three months, and thank our shareholders for their patience while we completed this critical work. We’re pleased to share the progress we’ve made this quarter through the following corporate update.”
Patient Enrollment
The Company has now onboarded over 12,000 patients and is continuing to add at least 2,000 new patients per month to the platform.
Company Evolution and Expansion
Reliq has undergone significant positive internal change over the last three months to enable accelerated growth going forward. This quarter the Company:
Hired an experienced Sales team consisting of three senior sales staff with a proven track record of generating more than $200M in sales of healthcare IT solutions. The Sales team will be in place by mid-April, allowing the Company to accelerate growth through both the existing pipeline leads and new opportunities.
Implemented a new Custom Relationship Management (CRM) system to improve lead tracking and reduce sales cycles.
Expanded the Implementation team to support new client deployments.
Migrated the iUGO Care platform code from a Toronto-based contract development provider to assume full ownership and control over the Company’s proprietary source code.
Built an internal Technical Leadership team to own and manage the Company’s code and direct all future Development efforts.
Expanded the Development team substantially while simultaneously reducing Development costs by engaging a highly respected, experienced contract development firm in Costa Rica.
Expanded the Finance team and is in the process of engaging new auditors.
Hired an Investor Relations resource to start in April to improve shareholder access to company information. To contact Investor Relations please email IR@reliqhealth.com.
To streamline the customer acquisition, client onboarding and patient enrollment processes the Company:
Opened a US office in McAllen, Texas to provide a base for the Sales team.
Added practice management and workflow support tools to the platform to provide clients with a turnkey solution for their organizations.
Created off-the-shelf training materials for new clients and patients including videos, online tutorials and printed materials.
Implemented automated claims submission to Medicare, Medicaid and private insurers.
Financial Position
On January 9th, 2018 the Company successfully closed an oversubscribed private placement led by Canaccord Genuity Corp and Gravitas Securities Inc. with gross proceeds of approximately $10,000,000.
Reliq currently has $13 Million CAD in cash and cash equivalents.
Upcoming Events
2018 ATA Conference
Reliq Health will be exhibiting at the American Telemedicine Association (ATA) Conference in Chicago, IL April 29 - May 1st, 2018. Come visit us at Booth #1428!
Reliq Health AGM
The Company will hold its Annual General Meeting (AGM) on May 15th at 10:00am PDT / 1:00pm EDT. Shareholders will receive the AGM materials in mid to late April.
Company Overview
Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq's powerful iUGO Care platform supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. Our platform provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.
Another program from RHT is placed for trial.
"Reliq Health Technologies Inc. (TSXV:RHT) or (OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on creating innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has begun onboarding diabetes patients for its Remote Patient Care pilot with Sioux Lookout Meno Ya Wen Health Centre in Sioux Lookout, ON. The pilot project is funded by Ontario’s Health Technologies Fund (HTF).
“We are very pleased to partner with Sioux Lookout Meno Ya Wen Health Centre (SLMHC) to address the healthcare challenge of poor access to care for diabetes patients living in remote and rural communities. With the use of our low-touch, high-tech iUGO Care solution, ‘virtual care’ can be provided to diabetes patients in their own communities throughout Northwestern Ontario,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Our platform supports remote patient monitoring and secure virtual communications, allowing clinicians to identify patients whose condition is becoming unstable and intervene early, before a serious complication develops. Sioux Lookout Meno Ya Wen Health Centre provides healthcare to patients across an area of Northwestern Ontario that is the size of France. Their commitment to delivering high quality care to patients in even the most remote communities in this area is inspiring, and we are honoured to be part of this important initiative.”
Sioux Lookout Meno Ya Wen Health Centre (www.slmhc.on.ca) in Sioux Lookout, Ontario provides health services to all residents in a large area of Northwestern Ontario that includes four municipalities and 28 First Nations communities, including the Nishnawbe-Aski communities north of Sioux Lookout, the Treaty #3 community of Lac Seul First Nation, Hudson, Pickle Lake and Savant Lake.
This pilot project is one of 15 that received funding in the first round of Ontario’s $20-million Health Technology Fund. The fund is administered by Ontario Centres of Excellence (OCE) on behalf of the Office of the Chief Health Innovation Strategist (OCHIS), and is a part of the OCHIS mandate to strengthen Ontario’s health innovation ecosystem. For more information please visit http://www.oce-ontario.org/programs/commercialization-programs/health-technologies-fund.
Reliq Health Technologies Named #1 2018 TSX Venture 50TM Performer, and Reaches 10,000 Patients Live on Its iUGO Care Platform
VANCOUVER, British Columbia, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT) (OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) solutions for Community-Based Healthcare, is pleased to announce it has achieved the #1 ranking in the 2018 TSX Venture 50™ in the technology sector. The TSX Venture 50™ is the TSX Venture Exchange’s annual ranking of Canada’s top 50 emerging publicly traded companies.
“We are honoured to have been recognized as the #1 technology stock in the TSX Venture 50™,” said Dr. Lisa Crossley, CEO of Reliq Health. “I want to thank the team at Reliq Health for their hard work, dedication and passionate commitment to building a business aimed at fundamentally disrupting the current model for healthcare. We also want to thank our shareholders, who have been so supportive of Reliq’s mission to reduce healthcare costs by improving health outcomes and access to care.”
The TSX Venture 50 acknowledges the top 10 performing companies listed on the TSX Venture Exchange in five industry sectors: mining, oil & gas, clean technology & life sciences, diversified industries, and technology. The winners are selected based on three equally weighted criteria: market capitalization growth, share price appreciation and trading volume. The TSXV created a video profile on Reliq and other 2018 TSX Venture 50™ winners, available at www.tsx.com/venture50.
Additionally, the company is pleased to announce that it now has 10,000 patients live on its iUGO Care chronic care management, remote patient monitoring and telemedicine platform.
Reliq’s iUGO Care digital health solution provides high quality virtual care in the community by creating a “virtual hospital ward” within the patient’s home, automatically collecting vital signs and encouraging and tracking medication adherence. iUGO Care’s unique interactive voice technology provides patients with audible alerts and reminders to take their medications, collect their vitals using Bluetooth-enabled monitoring devices and perform prescribed rehab or fitness activities. iUGO Care’s two-way voice hub provides voice-activated access to patient education content, empowering patients and family members to proactively manage complex chronic conditions. Reliq’s iUGO Care cloud platform instantly alerts the clinical care team if a patient develops key warning signs, allowing clinicians to intervene before a health crisis occurs, preventing costly and disruptive hospital readmissions and ER visits.
Hi Bobwins
I follow you so I saw your post here and took a look. I was actually a CFO/COO of a small company that is a competitor.
The "community care" space is a landmine field. What I saw is tons of customers with cashflow problems & difficulty making payments, bankruptcies (A/R writedowns), etc. The medicare rules on discharges creates an opportunity for companies like this to reduce re-admissions and thus provide value to hospitals. That said we still had difficulty with some larger organizations paying on time. The home healthcare industry is also rife with fraud against .gov entitlements which until this changes creates headwinds for these sorts of companies to get on a gov't gravy train (eg favorable legislation regarding reimbursement schemes for telehealth) & creates A/R risk for customers that get shut down by Medicare. Devices that collect & transmit health information (eg weight, blood pressure, O2, etc) fall under FDA regulation as medical devices. Many operators in this space are relatively new and haven't registered with the FDA (not sure if Reliq is or isn't) but that's something to take a look at if you have this on your watch list. I think it is only a matter of time before the FDA compliant companies start to rat out their non-compliant competitors.
80% GM is possible if the revenue is largely recurring revenue and particularly if Reliq devices capitalize on home WIFI where available. The space has plenty of competitors to include some big/well capitalized companies. I haven't looked deep enough to know if Reliq has some special sauce that is going to disrupt the space but if they don't than this is trading at a ridiculously high valuation.
I can appreciate your concerns. But what you haven't included in your projections is the potential of management to get "green light' on projects that are being trialed in other areas eg England, other states. Any confirmations would greatly accelerate growth of population and thus revenue. RHT's program is proving its worth to health systems. There are many companies who have programs but RHT seems to be leading the pack in getting acceptance. For whatever reason, it is working better than others. The insurance companies IN USA love their savings.
I just found RHT.v yesterday. Got all excited and was going to buy this morning. But I'm having a little trouble with the valuation.
Current revs are $300K/month, increasing to 1.5million/month by 12/18, assuming they can install in 24,000 homes by 12/18. Gross margins of 80%, which sounds really high.
Gross revs 30million. Let's ballpark expenses of 10million and leave a $20million net profit minus 5million in taxes = $15million divided by 150million shares= .10 eps. So it's selling for 20X forward earnings IF it achieves all it's growth goals for 2018. And it proves it can install tens of thousands of homes every year.
Plus I don't believe they achieved profitability in December. It's some "version" of profitability. At current income of 300K/month, I just don't believe it. Probably cashflow positive for the first time.
Market cap is around $300million for a company generating 3.6 million in annual sales?
I don't own any and probably won't. Congrats to anyone that bought below a buck! Woohoo!!!! Would have loved to be a significant holder with a cost basis of .20 or .30 and be holding a tenbagger. I think I just missed the boat. Good luck Bobwins
Reliq Health to host quarterly conference call March 1
2018-02-15 10:07 CT - News Release
Shares issued 82,095,165
RHT Close 2018-02-15 C$ 1.90
An anonymous director reports
RELIQ HEALTH ANNOUNCES CALL-IN DETAILS FOR QUARTERLY REPORTING CALL TO TAKE PLACE ON MARCH 1, 2018
Reliq Health Technologies Inc. will host an investor update conference call to review the company's recent progress and answer questions from shareholders.
Conference call information
When: March 1, 2018, 8 a.m. PT/11 a.m. ET
ID: 8886577
Dial-in (Canada and United States): 844-461-9931
Dial-in (international): 636-812-6630
The company would like to advise participants to join the conference call at least 10 minutes early in order to register. Investors are encouraged to submit questions in advance to info@reliqhealth.com as these questions will be addressed first, following which the moderator will open up the call to questions from investors who have registered and joined the queue. To join the queue participants will be asked to key in star 1 at any point in the call. Once the questions submitted in advance via e-mail have been addressed, the moderator will open the line to callers in the queue one at a time in order of priority. A recording of the conference call will be available afterward until March 8, 2018, and will be accessible by calling either of the following numbers: 855-859-2056 or 404-537-3406.
gLAD YOU FOUND US! THE LINK WE POSTED DOESN'T SEEM SPECIFIC ENOUGH.
WILL TRY TO GET ONE THAT WORKS BETTER
Hey, thanks for the invite. Hopefully we can have some quality discussions over here.
RELIQ HEALTH TECHNOLOGIES REACHES OVER 2,000 PATIENTS LIVE ON ITS IUGO CARE PLATFORM
Reliq Health Technologies Inc. has over 2,000 paid subscribers using its iUGO Care chronic care management, remote patient monitoring and telemedicine platform, representing recurring monthly revenue of over $100,000 (U.S.) per month.
"We are excited to announce that we now have over 2,000 patients live on our iUGO Care platform," said Dr. Lisa Crossley, CEO of Reliq Health." The on boarding of patients is starting to accelerate as we move forward with our rollout to over 40,000 patients in Texas. We expect to continue to enroll more than 1,000 new patients per month through 2018 with our two contracts with Paz Home Health LLC and Rio Grande Valley Health Alliance LLC, which together are worth over $26-million (U.S.) annually in recurring revenue at full deployment. We are proud to offer a solution that comprehensively and cost-effectively addresses the needs of frontline care providers in the community and the more than 37 million Medicare and Medicaid patients who have two or more chronic conditions."
Reliq is also pleased to announce that it has launched a new version of its corporate website, incorporating improved functionality and expanded content. The site will allow visitors to gain a comprehensive understanding of Reliq's business model and provide an industry-leading resource for information on the community health care market. Reliq's iUGO Care digital health solution provides high-quality virtual care in the community by creating a virtual hospital ward within the patient's home, automatically collecting vital signs and tracking medication adherence. iUGO Care's interactive voice technology provides patients with audible alerts and reminders to take their medications, collect their vitals using Bluetooth-enabled monitoring devices and perform prescribed rehab or fitness activities. iUGO Care's two-way voice hub provides voice-activated access to patient education content, empowering patients and family members to pro-actively manage complex chronic conditions. Reliq's iUGO Care cloud platform instantly alerts the clinical care team if a patient develops key warning signs, allowing clinicians to intervene before a health crisis occurs and preventing costly and disruptive hospital readmissions and ER visits.
Reliq Health Technologies Announces Closing of Oversubscribed $10 Million Brokered Private Placement Co-led by Canaccord Genuity and Gravitas Securities
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES
VANCOUVER, British Columbia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT) or (OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce further to its news release dated December 12, 2017, it successfully closed an oversubscribed private placement (the “Offering”) led by Canaccord Genuity Corp and Gravitas Securities Inc. (together, the “ Agents”) of 8,928,571 Units (the “Units”) of the Company at a price of $1.12 per Unit (the “Unit Price”) for gross proceeds of approximately $10,000,000.
Each Unit consists of one (1) common share of the Company (a “Common Share”) and half of one (1/2) Common Share purchase warrant (each whole Common Share purchase warrant, a “Warrant”). Each of the 4,464,285 Warrants is exercisable to acquire one Common Share (a “Warrant Share”) for a period of two years following the closing date of the Offering at an exercise price of $1.75 per Warrant Share, subject to adjustment in certain events.
The Company intends to use the net proceeds of the Offering for general working capital, product development and customer acquisition.
In connection with the Offering, the Company paid the Agents a cash fee of approximately $800,000 and issued 446,428 Units to the Agents. Additionally, the Company issued 714,285 compensation warrants to the Agents and another selling dealer group member (the “Compensation Warrants”), with each Compensation Warrant entitling the holder to purchase one Unit of the Company at an exercise price of $1.12 for a period of two years following the closing date of the Offering. Each warrant issued under the Units is exercisable into one Common Share of the Company for a period of two years following the closing date of the Offering at an exercise price of $1.75 per Common Share, subject to adjustment in certain events.
All securities issued in connection with the Offering are subject to a four month hold period expiring May 10, 2018.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
Let's establish a board that we will control. All posts that are positive or negative but cannot be repetitive, demeaning and should be based on FACTS.Consensus by mediator will be used as per the rules of Investorshub
Followers
|
10
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
123
|
Created
|
02/20/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |